Ziprasidone-Induced Pisa Syndrome after Clozapine Treatment [3]

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 15, Issue 4, 2003, Pages 458-459

  Ziegenbein, Marc ^a   Schomerus, Georg ^a   Kropp, Stefan ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; CLOZAPINE; ZIPRASIDONE;

ADULT; BLOOD ANALYSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; DYSTONIA; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; HYPERSALIVATION; LETTER; MOTOR DYSFUNCTION; PISA SYNDROME; PRIORITY JOURNAL; ROTATION; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; TRUNK; WEIGHT GAIN;

EID: 0345255938     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.15.4.458     Document Type: Letter

References (5)

1. Ekbom K, Lindholm H, Ljungberg I: New dystonic syndrome associated with butyrophenone therapy. Z Neurol 1972; 202:94-103
2. Suzuki T, Matsuzuka H: Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management. CNS Drugs 2002; 16(3):165-174
3. Stübner S, Padberg F, Grohmann R, Hampel H, Hollweg M, Hippius H, Möller HJ, Rüther E: Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project. J Clin Psychiatry 2000; 61:569-574
4. Rollema H, Lu Y, Schmidt AW, Spores JS, Zorn SH: 5-HT1A receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex. Biol Psychiatry 2000; 48:229-237
5. Barnes NM, Sharp T: A review of central 5-HT receptors and their function. Neuropsychopharmacology 1999; 38:1083-1152